These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36651516)

  • 1. Isolation of MDCK cells with low expression of
    Bokulić A; Padovan J; Stupin-Polančec D; Milić A
    Acta Pharm; 2022 Jun; 72(2):275-288. PubMed ID: 36651516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination.
    Chen EC; Broccatelli F; Plise E; Chen B; Liu L; Cheong J; Zhang S; Jorski J; Gaffney K; Umemoto KK; Salphati L
    Mol Pharm; 2018 Nov; 15(11):5103-5113. PubMed ID: 30222362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W
    Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.
    Kwatra D; Budda B; Vadlapudi AD; Vadlapatla RK; Pal D; Mitra AK
    Mol Pharm; 2012 Jul; 9(7):1877-86. PubMed ID: 22676443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1.
    Wegler C; Gazit M; Issa K; Subramaniam S; Artursson P; Karlgren M
    J Pharm Sci; 2021 Jan; 110(1):388-396. PubMed ID: 33007277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of P-glycoprotein and multidrug resistance protein in transporting para-aminosalicylic acid and its N-acetylated metabolite in mice brain.
    Hong L; Xu C; O'Neal S; Bi HC; Huang M; Zheng W; Zeng S
    Acta Pharmacol Sin; 2014 Dec; 35(12):1577-85. PubMed ID: 25418377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
    Karlgren M; Simoff I; Backlund M; Wegler C; Keiser M; Handin N; Müller J; Lundquist P; Jareborg AC; Oswald S; Artursson P
    J Pharm Sci; 2017 Sep; 106(9):2909-2913. PubMed ID: 28450237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.
    Feng B; West M; Patel NC; Wager T; Hou X; Johnson J; Tremaine L; Liras J
    J Pharm Sci; 2019 Jul; 108(7):2476-2483. PubMed ID: 30794795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
    Sato S; Tohyama K; Kosugi Y
    Eur J Pharm Sci; 2020 Jan; 142():105119. PubMed ID: 31682973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
    Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
    Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
    Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
    Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
    Horio M; Chin KV; Currier SJ; Goldenberg S; Williams C; Pastan I; Gottesman MM; Handler J
    J Biol Chem; 1989 Sep; 264(25):14880-4. PubMed ID: 2570070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
    Lala P; Ito S; Lingwood CA
    J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of optimized MDCK cell lines for reliable efflux transport studies.
    Gartzke D; Fricker G
    J Pharm Sci; 2014 Apr; 103(4):1298-304. PubMed ID: 24532159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
    Chen C; Hanson E; Watson JW; Lee JS
    Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells.
    Ortiz DF; Moseley J; Calderon G; Swift AL; Li S; Arias IM
    J Biol Chem; 2004 Jul; 279(31):32761-70. PubMed ID: 15159385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.